Page last updated: 2024-11-05

thioridazine and Developmental Disabilities

thioridazine has been researched along with Developmental Disabilities in 2 studies

Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA.
thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position.

Developmental Disabilities: Disorders in which there is a delay in development based on that expected for a given age level or stage of development. These impairments or disabilities originate before age 18, may be expected to continue indefinitely, and constitute a substantial impairment. Biological and nonbiological factors are involved in these disorders. (From American Psychiatric Glossary, 6th ed)

Research Excerpts

ExcerptRelevanceReference
"Those disorders discussed are attention deficit disorder, conduct disorders, anxiety disorders, sleep disorders, schizophrenia, autism, Tourette's syndrome, mental retardation, depressive illness, manic depressive illness, eating disorders, and enuresis."2.37Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1). ( McDaniel, KD, 1986)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brahm, NC1
Buswell, A1
Christensen, D1
Brown, RD1
McDaniel, KD1

Reviews

1 review available for thioridazine and Developmental Disabilities

ArticleYear
Pharmacologic treatment of psychiatric and neurodevelopmental disorders in children and adolescents (Part 1).
    Clinical pediatrics, 1986, Volume: 25, Issue:2

    Topics: Adolescent; Aggression; Antidepressive Agents; Antipsychotic Agents; Anxiety, Separation; Attention

1986

Other Studies

1 other study available for thioridazine and Developmental Disabilities

ArticleYear
Assessment of QTc prolongation following thioridazine withdrawal in a developmentally disabled population.
    Journal of clinical psychopharmacology, 2003, Volume: 23, Issue:3

    Topics: Adult; Child; Developmental Disabilities; Electrocardiography; Female; Humans; Long QT Syndrome; Mal

2003